Combination immunotherapy before surgery may increase survival in people with head and neck cancer: Clinical trial

Combination immunotherapy before surgery may increase survival in people with head and neck cancer: Clinical trial

Source: Medical Xpress

Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs) found that patients responded better to a combination of two immunotherapies than patients who received just one immunotherapy drug.

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Credit: Pixabay/CC0 Public Domain
Researchers conducting a clinical t… [3901 chars]

Read more

Leave a Comment

Your email address will not be published.

0